UPDATE: William Blair Upgrades DENTSPLY International (XRAY) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
BofA/Merrill Lynch Reinstates DENTSPLY International (XRAY) at Buy
March 18, 2019 8:16 AM EDTBofA/Merrill Lynch analyst Michael Cherny reinstates coverage on DENTSPLY International (NASDAQ: XRAY) with a Buy rating and a price target of $57.00.
in the throes of a significant transitionNew products + cost discipline = further outperformanceFor an analyst ratings summary and... More
